Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
3 min read
The Phase 3 TROPION-Breast01 trial showed Datopotamab Deruxtecan significantly improved progression-free survival in patients with HR positive, HER2 low/negative breast cancer
28 September 2023
The Phase 3 TROPION-Breast01 trial showed that Datopotamab Deruxtecan significantly improved progression-free survival for patients with HR positive, HER2 low or negative breast cancer.
Drug Insights
4 min read
Decoding Rocuronium Bromide: A Comprehensive Study of its R&D Trends
28 September 2023
This article summarized the latest R&D progress of Rocuronium Bromide, the Mechanism of Action for Rocuronium Bromide, and the drug target R&D trends for Rocuronium Bromide.
"What" Series
2 min read
What is DSMB?
28 September 2023
DSMB stands for Data Safety and Monitoring Board, an independent expert group established to safeguard the rights and needs of infants and young children participating in Phase III clinical trials.
Drug Insights
4 min read
Deep Scientific Insights on Ripretinib's R&D Progress, Mechanism of Action, and Drug Target
28 September 2023
This article summarized the latest R&D progress of Ripretinib, the Mechanism of Action for Ripretinib, and the drug target R&D trends for Ripretinib.
Latest Hotspot
3 min read
Antengene Declares Phase I Trial for ATG-031, an Anti-CD24 Monoclonal Antibody
28 September 2023
Antengene Corp Ltd obtained approval from University of Texas MD Anderson Cancer Center's Institutional Review Board for a Phase I trial of its prime anti-CD24 antibody, ATG-031, focusing on advanced hematology and oncology solutions.
Drug Insights
4 min read
An In-depth Analysis of Propantheline Bromide's R&D Progress and Mechanism of Action on Drug Target
28 September 2023
This article summarized the latest R&D progress of Propantheline Bromide, the Mechanism of Action for Propantheline Bromide, and the drug target R&D trends for Propantheline Bromide.
"What" Series
2 min read
What is MAH in Life Sciences?
28 September 2023
The full name is Marketing Authorization Holder. This typically refers to entities such as drug development institutions that possess drug technology, scientific researchers, and pharmaceutical manufacturing enterprises.
Drug Insights
4 min read
Pholcodine: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
28 September 2023
This article summarized the latest R&D progress of Pholcodine, the mechanism of action for Pholcodine, and the drug target R&D trends for Pholcodine.
Latest Hotspot
3 min read
Alvotech Gives U.S. Regulatory Progress Report on AVT02, a Humira® (adalimumab) Interchangeable Biosimilar Candidate with High Concentration
28 September 2023
Alvotech declared today that the U.S. FDA has agreed to Alvotech's revised BLA for AVT02.
Drug Insights
4 min read
Pentosan Polysulfate Sodium Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
28 September 2023
This article summarized the latest R&D progress of Pentosan Polysulfate Sodium, the mechanism of action for Pentosan Polysulfate Sodium, and the drug target R&D trends for Pentosan Polysulfate Sodium.
Drug Insights
4 min read
Unleashing the Power of Penicillin G Procaine: A Comprehensive Review on R&D Breakthroughs
28 September 2023
This article summarized the latest R&D progress of Penicillin G Procaine, the Mechanism of Action for Penicillin G Procaine, and the drug target R&D trends for Penicillin G Procaine.
Latest Hotspot
3 min read
Vir Biotechnology reports first subject treated in fresh Phase 1 trial of VIR-1388, a potential T cell HIV prevention vaccine under study
28 September 2023
Vir Biotechnology, Inc. reports first participant dosed in Phase 1 trial evaluating safety, reactogenicity, and immunogenicity of VIR-1388.